We are live on ! Find out more
QCOR

QUESTCOR PHARMA INC
QCOR

Delisted

QCOR was delisted on the 14th of August, 2014.

320 hedge funds and large institutions have $6.07B invested in QUESTCOR PHARMA INC in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 68 increasing their positions, 142 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more funds holding in top 10

Funds holding in top 10: 817 (+9)

50% more capital invested

Capital invested by funds: $4.06B → $6.07B (+$2.01B)

2% more funds holding

Funds holding: 313320 (+7)

9% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 79

52% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 142

79% less call options, than puts

Call options by funds: $349M | Put options by funds: $1.67B

Holders
320
Holders Change
+7
Holders Change %
+2.24%
% of All Funds
9.2%
Holding in Top 10
17
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+112.5%
% of All Funds
0.49%
New
86
Increased
68
Reduced
142
Closed
79
Calls
$349M
Puts
$1.67B
Net Calls
-$1.32B
Net Calls Change
-$1.12B
Name Holding Trade Value Shares
Change
Change in
Stake
OC
201
Oppenheimer & Co
New York
$1.09M -$2.95M -34,440 -74%
CCA
202
Catalyst Capital Advisors
New York
$1.09M +$117K +1,371 +13%
Nisa Investment Advisors
203
Nisa Investment Advisors
Missouri
$1.09M
CAS
204
CTC Alternative Strategies
Illinois
$1.05M +$702K +8,200 +265%
GIA
205
Gargoyle Investment Advisor
New Jersey
$985K -$2.06M -24,073 -69%
URS
206
Utah Retirement Systems
Utah
$980K +$908K +10,600 New
PRCM
207
Pine River Capital Management
Minnesota
$881K +$816K +9,530 New
AA
208
ALPS Advisors
Colorado
$879K +$20.6K +240 +3%
CEP
209
Chicago Equity Partners
Illinois
$862K -$2.27M -26,480 -74%
STIA
210
Stone Toro Investment Advisers
New Jersey
$851K +$788K +9,200 New
AAM
211
Advisors Asset Management
Colorado
$826K +$224K +2,618 +41%
ICAS
212
Investors Capital Advisory Services
Massachusetts
$818K -$124K -1,443 -14%
CIBC World Market
213
CIBC World Market
Ontario, Canada
$809K -$54.8K -640 -7%
PI
214
PineBridge Investments
New York
$806K -$451K -5,269 -38%
HCM
215
Highbridge Capital Management
New York
$797K -$3.51M -40,965 -83%
Nomura Holdings
216
Nomura Holdings
Japan
$796K -$11.8M -137,622 -94%
BA
217
BlackRock Advisors
Delaware
$796K -$6.96M -81,285 -90%
HM
218
Harvest Management
New York
$786K +$728K +8,500 New
AIG
219
American International Group
New York
$771K -$2.97M -34,653 -81%
TYCC
220
Texas Yale Capital Corp
Florida
$726K -$6.42K -75 -0.9%
LTFS
221
Ladenburg Thalmann Financial Services
Florida
$693K +$574K +6,704 +855%
OA
222
Oak Associates
Ohio
$680K
LIM
223
Leavell Investment Management
Alabama
$675K -$171K -2,000 -22%
Stifel Financial
224
Stifel Financial
Missouri
$660K -$6.16M -71,987 -91%
GI
225
GAMCO Investors
Connecticut
$657K +$608K +7,100 New

QCOR Hedge Fund Activity: Q2 2014 in Review

320 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q2 2014, worth a combined $6.07B — up 50% from $4.06B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new QCOR positions and 79 closed out — a net gain of 7 holders — while 68 added to existing stakes and 142 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $378M. The largest seller was Fidelity Investments, cutting an estimated $306M.

  • 320 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q2 2014, up from 313 in Q1 2014.
  • Funds reported $6.07B of QUESTCOR PHARMA INC stock for Q2 2014, up 50% quarter-over-quarter.
  • 86 funds opened new QUESTCOR PHARMA INC positions in Q2 2014 and 79 closed out, a net change of +7 holders.
  • The largest QUESTCOR PHARMA INC buyer in Q2 2014 was Adage Capital Partners, an estimated $378M added.
  • The largest QUESTCOR PHARMA INC seller in Q2 2014 was Fidelity Investments, an estimated $306M sold.

Based on aggregated 13F filings for Q2 2014.